Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations only indicate read-only, open-world, idempotent, and non-destructive behavior. The description adds substantial behavioral detail: the parallel fan-out across sources, the soft-fail for patents, empty sections meaning real 'no data', and the resolution logic for names/CIKs/tickers. This fully informs the agent about the tool's side effects and edge cases, going well beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, dense paragraph that front-loads the purpose and examples but then runs through all data fields and edge cases without any visual structure. It is informative but verbose; breaking it into bullets would improve readability. Still, every sentence contributes value, so it is not redundant, but it could be tightened.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (multiple data sources, many output fields, no output schema), the description thoroughly explains what will be returned: cik, company_name, recent_filings with URIs, fundamentals, patents, federal_contracts, fda_products (with note about small-molecule-only companies), hiring, news, LEI, and sources_used/sources_failed. It also covers the resolved:false case. This is complete enough for an agent to call it correctly and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so baseline is 3. The description adds meaning by explaining that 'type' accepts 'company' or 'ticker' interchangeably and that 'value' can take ticker, CIK, or name forms, with names resolving via SEC EDGAR. This clarifies parameter flexibility beyond the schema's basic enum and examples.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: creating a full cross-source profile of a US public company in a single call. It provides concrete example queries and explicitly contrasts with chaining single-pack lookups, making the tool's scope unmistakable and distinguishing it from sibling research tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance ('ALWAYS PREFER... when the user asks for a holistic view') and implies when not to use (for specific lookups like single filings). It also notes edge cases like private companies returning resolved:false, giving agents clear routing criteria without naming specific siblings.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation4/5

Most tools have clearly distinct purposes, but there is some overlap among similarly named tools like ask_pipeworx, deep_research, and bet_research, which could cause misselection. However, detailed descriptions help differentiate them.

Naming Consistency3/5

Tool names follow a mix of patterns (verb_noun, noun_noun, etc.) and use different prefixes (polymarket_, sec_8k_, pipeworx_), which is somewhat inconsistent but still readable and descriptive overall.

Tool Count3/5

34 tools is on the higher side, with several tools dedicated to specific subdomains (e.g., 6 Polymarket-related, 4 SEC 8-K tools). While each has a distinct role, the number feels slightly bloated for a single server.

Completeness4/5

The tool surface covers a broad range of data research and monitoring tasks, including filings, entity profiles, claims, and prediction markets. Minor gaps exist (e.g., no data writing tools), but core workflows are well-supported.